CEO Steven Cunningham Sells $1.89M in Enova International Stock Following Option Exercise
ENVA has more than doubled off its 52-week low of $79.407 on elevated volume (2.7× avg).
Summary
Enova International CEO Steven Cunningham sold approximately $1.89 million worth of company stock after exercising options, marking a notable insider disposition.
Key Events · Ownership and Investor Activity · ENVA
-
CEO Stock Sale
CEO Steven Cunningham sold 11,436 shares of Enova International common stock for a total value of approximately $1.89 million at an average price of $165.13 per share.
-
Option Exercise
The sale followed the exercise of options to acquire an equal number of shares at a strike price of $20.73 per share, valued at $237,068.
-
Timing Post-Earnings
This insider sale occurred on January 30, 2026, just days after the company reported strong fourth quarter and full year 2025 financial results on January 27, 2026.
Analysis · ENVA · Finance
This Form 4 filing indicates that CEO Steven Cunningham exercised options to acquire shares and subsequently sold all of those shares in the open market. While the exercise of options is a common compensation event, the immediate sale of nearly $1.9 million worth of stock by a key executive, especially following the company's recent strong earnings report on January 27, 2026, could be interpreted as a signal of an insider monetizing gains. This transaction contributes to a broader pattern of insider distribution observed over the last 90 days.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENVA was trading at $159.07 on NYSE in the Finance sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $79.41 to $176.68. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.